Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

ADMA Biologics, Inc.

NASDAQ: ADMAHealthcare / Biotechnology / USA
4.0000.00Vol 3 8691Y Perf 3.68%
Feb 21st, 2019 09:37
BID4.01 ASK4.05
Open4.00 Previous Close4.00
Pre-Market- After-Trading4.05
 - -%  0.05 1.25%
Target Price
9.71 
Analyst Rating
Strong Buy 1.20
Potencial %
139.75 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/100 
Growth Ranking
★★     44.51
Insiders Shares Cnt. % 3/6/12M
-/-/100 
Income Ranking
 —    -
Market Cap (mil)185 
Earnings Rating
Strong Sell
Price Range Ratio 52wk %
39.34 
Earnings Date
4th Mar 2019

Today's Price Range

4.004.05

 

52wk Range

2.086.96

Summary:

Neutral

Technical Indicators: Sell
Moving Averages: Buy
Performance
1 Month
19.05%
3 Months
-21.57%
6 Months
-29.20%
1 Year
3.68%
3 Years
-8.26%
5 Years
-52.94%

Quotes

Name / TickerPriceChg.Chg.%
ADMA4.000.00000.00
AAPL171.94-0.0900-0.05
GOOG1 103.53-10.2700-0.92
MSFT107.330.18000.17
XOM78.640.11000.14
WFC49.71-0.1000-0.20
JNJ134.51-1.8400-1.35
FB161.44-1.1200-0.69
GE10.09-0.0100-0.10
JPM105.830.14000.13
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
4.70
Current Ratio
6.30
Long Term Debt to Total Capital
0.54
Total Debt to Equity
1.18
Interest Coverage
-10.40
Leverage Ratio 2.80
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-72.40
EBIT Margin
-222.10
EBITDA Margin
-206.10
Pre-tax Profit Margin
-222.30
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
4.34
PS Ratios
13.81
Price to Cash Flow
-
Price to Free Cash Flow
-3.60
Cash Flow Per Share
-1.34
Price to Tangible Book
5.48
Book Value per Share
0.80
Enterprise Value (in ths.)
162 871
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-232.64
ROE last 12 Months
-241.79
Return on Assets (5Y Avg)
-25.36
ROA last 12 Months
-67.75
Return on Capital (5Y Avg)
-
ROC last 12 Months
-88.60
Return on invested Capital Q
-15.64
Return on invested Capital Y
-87.18
Assets Turnover
0.10
Receivables Turnover
2.00
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
12 822
Revenue per Share
0.28
Revenue Growth 3 Years
24.34
Revenue Growth 5 Years
35.91
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.33-0.330.00
Q02 2018-0.32-0.35-9.38
Q01 2018-0.27-0.35-29.63
Q04 2017-0.51-0.2452.94
Q03 2017-0.510.59215.69
Q02 2017-0.42-0.55-30.95
Q01 2017-0.22-0.51-131.82
Q04 2016-0.33-0.35-6.06
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.33-10.00Negative
12/2018 FY-1.39-1.46Negative
3/2019 QR-0.30-66.67Negative
12/2019 FY-0.81-47.27Negative
Next Report Date4th Mar 2019
Estimated EPS Next Report-0.33
Estimates Count4
EPS Growth Next 5 Years %-
Volume Overview
Volume3 869
Shares Outstanding (in ths.)46 351
Trades Count36
Dollar Volume33 673
Avg. Volume556 082
Avg. Weekly Volume481 192
Avg. Monthly Volume735 073
Avg. Quarterly Volume443 018

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

55%45%

Bearish Bullish

54%46%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (80.00 %)
4 (80.00 %)
4 (80.00 %)
Moderate Buy
1 (20.00 %)
1 (20.00 %)
1 (20.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.20
Strong Buy
1.20
Strong Buy
1.20

There are no comments yet.

News